At a July meeting in Saratoga Springs, the Association of Racing Commissioners International (ARCI) approved a model rule described by the organization as the third of three measures designed to address inconsistencies in national medication policies in Thoroughbred horse racing (here).

Just about two months later, details of the system have yet to reach the backstretches of Mid-Atlantic racetracks.

Continue reading at The Racing Biz…